Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  722 results for ""Interleukin-23 Subunit p19""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Targeting the Interleukin 23 Pathway in Inflammatory Bowel Disease.

  • Authors : Bourgonje AR; The Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

Subjects: Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/drug therapy ; Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/immunology ; Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/Inflammatory Bowel Diseases*/metabolism

  • Source: Gastroenterology [Gastroenterology] 2025 Jan; Vol. 168 (1), pp. 29-52.e3. Date of Electronic Publication: 2024 Jun 28.Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0374630 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

IL-23p19 in osteoarthritic pain and disease.

  • Authors : Lee KM; Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria 3050, Australia. Electronic address: .; Lupancu T

Subjects: Osteoarthritis, Knee*/Osteoarthritis, Knee*/Osteoarthritis, Knee*/metabolism ; Osteoarthritis, Knee*/Osteoarthritis, Knee*/Osteoarthritis, Knee*/genetics ; Interleukin-23 Subunit p19*/Interleukin-23 Subunit p19*/Interleukin-23 Subunit p19*/genetics

  • Source: Osteoarthritis and cartilage [Osteoarthritis Cartilage] 2024 Nov; Vol. 32 (11), pp. 1413-1418. Date of Electronic Publication: 2024 Jun 04.Publisher: W.B. Saunders For The Osteoarthritis Research Society Country of Publication: England NLM ID: 9305697 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Selection and evaluation of single domain antibody against p19 subunit of IL-23 by phage display for potential use as an autoinflammatory therapeutic.

  • Authors : Abdo AIK; Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia. Electronic address: .; Nordin F

Subjects: Interleukin-23 Subunit p19*/Interleukin-23 Subunit p19*/Interleukin-23 Subunit p19*/immunology ; Interleukin-23 Subunit p19*/Interleukin-23 Subunit p19*/Interleukin-23 Subunit p19*/genetics ; Single-Domain Antibodies*/Single-Domain Antibodies*/Single-Domain Antibodies*/immunology

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 Aug 20; Vol. 137, pp. 112371. Date of Electronic Publication: 2024 Jun 08.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Interleukin-23 p19 and Interleukin-12 p40, Head-to-Head, against Gut Inflammation.

  • Authors : Abraham C; From Yale University, New Haven, CT.

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/immunology ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Crohn Disease*/Crohn Disease*/Crohn Disease*/diagnosis

  • Source: The New England journal of medicine [N Engl J Med] 2024 Jul 18; Vol. 391 (3), pp. 275-277.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A Novel Human Interleukin-23A Overexpressing Mouse Model of Systemic Lupus Erythematosus.

Subjects: Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/genetics ; Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/immunology ; Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/drug therapy

  • Source: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2024 Jul; Vol. 76 (7), pp. 1085-1095. Date of Electronic Publication: 2024 Apr 02.Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Altered serum interleukin-17A and interleukin-23A levels may be associated with the pathophysiology and development of generalized anxiety disorder.

  • Authors : Mamun-Or-Rashid; Department of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka, 1000, Bangladesh.; Roknuzzaman ASM

Subjects: Interleukin-17*/Interleukin-17*/Interleukin-17*/blood ; Anxiety Disorders*/Anxiety Disorders*/Anxiety Disorders*/blood ; Anxiety Disorders*/Anxiety Disorders*/Anxiety Disorders*/physiopathology

  • Source: Scientific reports [Sci Rep] 2024 Jul 02; Vol. 14 (1), pp. 15097. Date of Electronic Publication: 2024 Jul 02.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Chemotherapy-induced high expression of IL23A enhances efficacy of anti-PD-1 therapy in TNBC by co-activating the PI3K-AKT signaling pathway of CTLs.

  • Authors : Pan F; Department of Oncology, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Eastern Zhongshan Road 305#, Nanjing, 210002, China.; Liu J

Subjects: Proto-Oncogene Proteins c-akt*/Proto-Oncogene Proteins c-akt*/Proto-Oncogene Proteins c-akt*/metabolism ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/metabolism

  • Source: Scientific reports [Sci Rep] 2024 Jun 20; Vol. 14 (1), pp. 14248. Date of Electronic Publication: 2024 Jun 20.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Understanding the impact of risankizumab on keratinocyte-derived IL-23A in a novel organotypic 3D skin model containing IL-23A responsive and IL-17A producing γδ-T-cells.

  • Authors : Huth L; Department of Dermatology and Allergology, Medical Faculty, RWTH Aachen University, Aachen, Germany.; Amann PM

Subjects: Interleukin-17*/Interleukin-17*/Interleukin-17*/metabolism ; Keratinocytes*/Keratinocytes*/Keratinocytes*/drug effects ; Keratinocytes*/Keratinocytes*/Keratinocytes*/metabolism

  • Source: Cutaneous and ocular toxicology [Cutan Ocul Toxicol] 2024 Jun; Vol. 43 (2), pp. 124-128. Date of Electronic Publication: 2024 Feb 02.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101266892 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Tolerability and comparative effectiveness of TNF, IL-17 and IL-23(p19) inhibitors in psoriatic arthritis: a target trial emulation study.

  • Authors : Stisen ZR; The Parker Institute, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.; Nielsen SM

Subjects: Arthritis, Psoriatic*/Arthritis, Psoriatic*/Arthritis, Psoriatic*/drug therapy ; Interleukin-17*/Interleukin-17*/Interleukin-17*/antagonists & inhibitors ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use

  • Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 May 03; Vol. 63 (6), pp. 1543-1551.Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Multifaceted Analysis of IL-23A- and/or EBI3-Including Cytokines Produced by Psoriatic Keratinocytes.

  • Authors : Tachibana K; Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science, 2-5-1 Shikata-cho, Kitaku, Okayama 700-8558, Japan.; Tang N

Subjects: Up-Regulation*/Up-Regulation*/Up-Regulation*/drug effects; Interleukin-23 Subunit p19/Interleukin-23 Subunit p19/Interleukin-23 Subunit p19/*metabolism ; Interleukins/Interleukins/Interleukins/*metabolism

  • Source: International journal of molecular sciences [Int J Mol Sci] 2021 Nov 23; Vol. 22 (23). Date of Electronic Publication: 2021 Nov 23.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read More Add to Saved list
×
  • 1-10 of  722 results for ""Interleukin-23 Subunit p19""